Xvivo Perfusion Valuation
| XVIVO Stock | SEK 480.00 7.50 1.59% |
At this time, the company appears to be fairly valued. Xvivo Perfusion AB maintains a prevalent Real Value of kr470.16 per share. The last-minute price of the company is kr480.0. Our model calculates the value of Xvivo Perfusion AB from examining the company fundamentals such as Current Valuation of 5.54 B, return on asset of 0.0057, and Profit Margin of 0.04 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Xvivo Perfusion's price fluctuation is very steady at this time. Calculation of the real value of Xvivo Perfusion AB is based on 3 months time horizon. Increasing Xvivo Perfusion's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Xvivo stock is determined by what a typical buyer is willing to pay for full or partial control of Xvivo Perfusion AB. Since Xvivo Perfusion is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xvivo Stock. However, Xvivo Perfusion's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 480.0 | Real 470.16 | Hype 480.0 | Naive 493.64 |
The intrinsic value of Xvivo Perfusion's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xvivo Perfusion's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Xvivo Perfusion AB helps investors to forecast how Xvivo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xvivo Perfusion more accurately as focusing exclusively on Xvivo Perfusion's fundamentals will not take into account other important factors: Xvivo Perfusion Total Value Analysis
Xvivo Perfusion AB is at this time projected to have takeover price of 5.54 B with market capitalization of 7.48 B, debt of 1.52 M, and cash on hands of 398.7 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Xvivo Perfusion fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.54 B | 7.48 B | 1.52 M | 398.7 M |
Xvivo Perfusion Investor Information
About 12.0% of the company outstanding shares are owned by insiders. The book value of Xvivo Perfusion was at this time reported as 47.94. The company has Price/Earnings (P/E) ratio of 662.55. Xvivo Perfusion AB had not issued any dividends in recent years. Based on the analysis of Xvivo Perfusion's profitability, liquidity, and operating efficiency, Xvivo Perfusion AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Xvivo Perfusion Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Xvivo implies not a very effective usage of assets in December.Xvivo Perfusion Ownership Allocation
Xvivo Perfusion AB retains a total of 29.83 Million outstanding shares. Over half of Xvivo Perfusion's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Xvivo Perfusion AB. Please watch out for any change in the institutional holdings of Xvivo Perfusion AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Xvivo Perfusion Profitability Analysis
The company reported the revenue of 258.39 M. Net Income was 8.15 M with profit before overhead, payroll, taxes, and interest of 296.96 M.About Xvivo Perfusion Valuation
The stock valuation mechanism determines Xvivo Perfusion's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Xvivo Perfusion AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xvivo Perfusion. We calculate exposure to Xvivo Perfusion's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xvivo Perfusion's related companies.Xvivo Perfusion AB , a medical technology company, provides solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. Xvivo Perfusion AB was founded in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 45 people.
8 Steps to conduct Xvivo Perfusion's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Xvivo Perfusion's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Xvivo Perfusion's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Xvivo Perfusion's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Xvivo Perfusion's revenue streams: Identify Xvivo Perfusion's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Xvivo Perfusion's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Xvivo Perfusion's growth potential: Evaluate Xvivo Perfusion's management, business model, and growth potential.
- Determine Xvivo Perfusion's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Xvivo Perfusion's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Xvivo Stock Analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.